Histamine H2-receptor antagonist in treatment of peptic ulcer
Wyllie, J.H.
Postgraduate Medicine 63(4): 91
1978
ISSN/ISBN: 0032-5481 PMID: 345252 Document Number: 126836
Cimetidine promotes the healing of duodenal ulcer, but prolonged use (perhaps in low dosage) seems to be necessary in many cases to prevent relapse. H2 receptors are widely distributed in body tissue, but important effects of blockade of the extragastric receptors have not been detected. Nor has serious toxicity been noted. Cimetidine probably will become a familiar, much-used, and valuable drug.
Document emailed within 1 workday
Related Documents
Radbil', O.S. 1977: Treatment of peptic ulcer with histamine H2-receptor antagonists Sovetskaia Meditsina 11: 111-119Belousov, A.S.; Leont'eva, G.V.; Rakitskaia, L.G.; Kolesova, O.E.; Lebkova, N.P.; Akhmad Khzhuzh 1990: Effects of cimetidine, a H2-histamine blocker, on ulcer cicatrization processes in patients with peptic ulcer localized in the duodenal bulb Klinicheskaia Meditsina 68(3): 96-99
Habu, Y.; Yoshino, T.; Shio, S.; Hayakumo, T.; Kawai, K. 2004: Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1504-1509
Kamada, T.; Kusunoki, H.; Manabe, N.; Shiotani, A.; Hata, J.; Haruma, K. 2007: Histamine-2 receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 65(10): 1835-1840
Meyer, B.H.; Müller, F.O.; Badian, M.; Hundt, H.K.; Joubert, A.L.; Luus, H.G. 1988: Effects of HOE 760 (histamine H2-receptor antagonist) on diazepam pharmacokinetics South African Medical Journal 73(7): 421-423
Brimblecombe, R.W.; Duncan, W.A.; Durant, G.J.; Emmett, J.C.; Ganellin, C.R.; Leslie, G.B.; Parsons, M.E. 1978: Characterization and development of cimetidine as a histamine H2-receptor antagonist Gastroenterology 74(2 Part 2): 339-347
Poizot, A.; Dumez, D.; Ferrandon, P.; Lefournier, C.; Michel, A.; Armstrong, J.M. 1986: Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline Arzneimittel-Forschung 36(4): 695-702
Ligneau, X.; Lin, J.; Vanni-Mercier, G.; Jouvet, M.; Muir, J.L.; Ganellin, C.R.; Stark, H.; Elz, S.; Schunack, W.; Schwartz, J. 1998: Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist Journal of Pharmacology and Experimental Therapeutics 287(2): 658-666
Barbezat, G.O.; Bank, S. 1976: Effect of a histamine H2-receptor antagonist and an anticholinergic on gastric acid secretion in man South African Medical Journal 50(22): 849-851
Zak-Nejmark, T.; Małolepszy, J.; Nadobna, G.; Kuczyńska-Sekieta, K.; Marczyńska-Sarul, E.; Jutel, M. 1992: Specific immunotherapy stimulates the binding of histamine H2 receptor antagonist by lymphocytes Archivum Immunologiae et Therapiae Experimentalis 40(2): 113-116
Klima, P. 1984: Experiences with the histamine-H2-receptor antagonist ranitidine in the prevention of stress ulcers Wiener Medizinische Wochenschrift 134(15-16): 369-373
Necciari, J.; Mery, D.; Garriot, P.; Escourrou, J.; Cautreels, W. 1985: Pharmacokinetics of CM 57755, a new histamine H2-receptor antagonist, after single oral doses in man International Journal of Clinical Pharmacology Research 5(6): 457-465
Ivashkin, V.T.; Tkachenko, E.I.; Grinevich, V.B.; Sultanov, V.K.; Inozemtsev, S.A. 1989: A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer Terapevticheskii Arkhiv 61(8): 59-62
Inamori, M.; Iida, H.; Hosono, K.; Endo, H.; Sakamoto, Y.; Takahashi, H.; Koide, T.; Tokoro, C.; Goto, A.; Abe, Y.; Hiratsuka, N.; Nakajima, A.; Fujita, M. 2010: The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease Hepato-Gastroenterology 57(104): 1430-1434
Kruse, K.M.; Huber, T.; Grosse-Heitmeyer, W. 1992: Effects of histamine on pulmonary artery system in humans after pretreatment with an H2-receptor-antagonist International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 445-446
Kishimoto, W.; Hiroi, T.; Sakai, K.; Funae, Y.; Igarashi, T. 1997: Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine Research Communications in Molecular Pathology and Pharmacology 98(3): 273-292
Cieślewicz, G.; Gondorowicz, K.; Grzelewska-Rzymowska, I.; Rozniecki, J.; Wojciechowska, B. 1992: Effect of loratadine--selective antagonist of histamine (H1) receptor--on allergen-induced bronchoconstriction in atopic asthmatics Pneumonologia i Alergologia Polska 60(11-12): 11-15
Carter, D.C.; Forrest, J.A.; Logan, R.A.; Ansell, I.; Lidgard, G.; Heading, R.C.; Shearman, D.J. 1976: Effect of the histamine H2-receptor antagonist, cimetidine, on gastric secretion and serum gastrin during insulin infusion in man Scandinavian Journal of Gastroenterology 11(6): 565-570
Katz, L.B.; Scott, C.K.; Shriver, D.A. 1986: Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine Journal of Pharmacology and Experimental Therapeutics 238(2): 587-593
Szymura-Oleksiak, J.; Kryczyk, A.; Szafarz, M.łg.; Jawień, W.; Łazewska, D.; Kieć-Kononowicz, K. 2012: Binding of 1-[3-(4-tert-butyl-phenoxy)propyl]piperidine, a new non imidazole histamine H3 receptor antagonist to bovine serum albumin Acta Poloniae Pharmaceutica 69(6): 1043-1047